top of page


How AI is Improving Drug Development and Pharmacovigilance?
AI is revolutionizing drug development and pharmacovigilance by accelerating discovery, automating safety reporting, and enhancing compliance. Discover how Tesserblu enables intelligent, end-to-end transformation.
Chailtali Gaikwad
Jul 3, 20255 min read
Â
Â
Â


Improving Pharmacovigilance Compliance with AI-Driven Regulatory Insights
AI-driven regulatory insights are transforming pharmacovigilance by enabling real-time monitoring, improving compliance, reducing risk, and streamlining decision-making across global drug safety operations.
Chailtali Gaikwad
Jun 13, 20255 min read
Â
Â
Â


The Role of Automation in Regulatory Compliance for Aggregate Reporting
In the highly regulated pharmaceutical and life sciences industries, ensuring compliance with safety reporting requirements is critical....
Chailtali Gaikwad
Jun 5, 20255 min read
Â
Â
Â


How Machine Learning is Improving the Speed and Quality of Aggregate Reports
Machine learning is revolutionizing aggregate reporting by enhancing speed, accuracy, and compliance—enabling faster, data-driven safety assessments and improving overall pharmacovigilance efficiency.
Chailtali Gaikwad
Jun 5, 20255 min read
Â
Â
Â


AI-Driven Case Intake: Enhancing Drug Safety Compliance and Efficiency
Pharmacovigilance (PV) is the backbone of drug safety, tasked with the critical responsibility of detecting, assessing, and preventing...
Chailtali Gaikwad
May 23, 20255 min read
Â
Â
Â


AI vs. Manual Literature Review: Which One Ensures Better Compliance?
Discover how AI enhances literature review in pharmacovigilance, ensuring faster, more accurate compliance compared to manual methods—without compromising regulatory standards or human oversight.
Chailtali Gaikwad
May 23, 20254 min read
Â
Â
Â
bottom of page
